45. When the Secretary of State issues the marketing authorisation he must approve all containers, packaging, labels and package leaflets.
46. A label and package leaflet of an authorised veterinary medicinal product may contain in legible characters the words “UK authorised veterinary medicinal product” or, if the marketing authorisation provides, other wording specified in the authorisation indicating that the product is authorised in the United Kingdom.
47.—(1) All labels and package leaflets must be in English, but may contain other languages provided that the information given is identical in all the languages.
(2) This requirement does not apply in the case of a product imported by a veterinary surgeon and administered by or under the responsibility of that same veterinary surgeon.
48.—(1) If it is reasonably practicable to do so, the following must be provided on the immediate packaging, in legible characters—
(a)the name, strength and pharmaceutical form of the veterinary medicinal product;
(b)the name and strength of each active substance, and of any excipient if this is required under paragraph 2 of the summary of product characteristics;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and if appropriate, “To be supplied only on veterinary prescription”;
(g)the contents by weight, volume or number of dose units;
(h)the marketing authorisation number;
(i)the name and address of the marketing authorisation holder or, if there is a distributor authorised in the marketing authorisation, that distributor;
(j)a suitably labelled space to record discard date (if relevant);
(k)the target species;
(l)the distribution category;
(m)the words “Keep out of reach of children”;
(n)storage instructions;
(o)the in-use shelf-life (if appropriate);
(p)for food-producing species, the withdrawal period for each species or animal product concerned;
(q)any warning specified in the marketing authorisation;
(r)disposal advice;
(s)full indications;
(t)dosage instructions;
(u)contra-indications;
(v)further information required in the marketing authorisation;
(w)if the product is one that requires a dose to be specified for the animal being treated, a space for this.
(2) If all this is on the immediate packaging, there is no need for any outer packaging or a package leaflet.
49.—(1) If it is not reasonably practicable to have all the required information on the immediate packaging then this paragraph applies.
(2) The immediate packaging must have at least the following information—
(a)the name of the veterinary medicinal product, including its strength and pharmaceutical form;
(b)the name and proportion of each active substance, and of any excipient if knowledge of the excipient is needed for safety reasons;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and if appropriate, “To be supplied only on veterinary prescription”;
(g)the words “Keep the container in the outer carton”.
(3) In addition, the immediate packaging must have as much of the required information as is reasonably practicable.
(4) The outer packaging must contain all the required information if it is reasonably practicable to do this, and if it is not reasonably practicable to do this a package leaflet must be supplied with the product in accordance with the following paragraph.
50.—(1) If it is not reasonably practicable to have all the required information on the immediate packaging or all of this information on the outer packaging, there must be a package leaflet supplied with the product, containing all the required information except for the batch number and the expiry date, and including the name of both the marketing authorisation holder and, if different, the name of the distributor named in the marketing authorisation.
(2) If there is a package leaflet, the immediate packaging and the outer packaging must both refer the user to it.
(3) A package leaflet must relate solely to the veterinary medicinal product with which it is included.
(4) It must be written in plain English.
(5) Only a package leaflet approved in the marketing authorisation may be included with the veterinary medicinal product.
51.—(1) In the case of ampoules or other unit dose forms, where the container cannot bear legibly the required information, only the following information must be shown on the immediate packaging—
(a)the name of the veterinary medicinal product;
(b)the name and strength of the active ingredient;
(c)the route of administration (if not immediately apparent);
(d)the batch number;
(e)the expiry date;
(f)the words “For animal treatment only” and if appropriate, “To be supplied only on veterinary prescription”.
(2) The outer packaging must contain all the required information if it is reasonably practicable to do this, and if it is not reasonably practicable to do this a package leaflet must be supplied with the product, except that the ampoule need not refer to the package leaflet.
52. As regards small immediate packaging containing a single dose, other than ampoules, on which it is impossible to give the required information, all the required information must appear on the outer packaging or outer packaging and package leaflet, but the immediate packaging must be labelled with the batch number and the expiry date and, if there is room, the other information in the preceding paragraph.
53.—(1) A homeopathic remedy registered under these Regulations must be labelled in accordance with this paragraph.
(2) There must be no specific therapeutic indication on the labelling or in any information relating to it.
(3) The labelling (or labelling and package leaflet) must contain the following and no other information—
(a)the words “homeopathic remedy without approved therapeutic indications for veterinary use”;
(b)the scientific name of the stock or stocks followed by the degree of dilution, using the symbols of the pharmacopoeia used (if the homeopathic remedy is composed of more than one stock, the labelling may mention an invented name in addition to the scientific names of the stocks);
(c)the name and address of the registration holder and (on the package leaflet) of the manufacturer;
(d)the method and, if necessary, route of administration;
(e)the expiry date;
(f)the pharmaceutical form;
(g)the contents of the pack;
(h)any special storage precautions;
(i)the target species;
(j)any necessary special warnings;
(k)the batch number; and
(l)the registration number.
54. The Secretary of State may permit variations in the above in any individual marketing authorisation if this is necessary for public or animal health purposes or the protection of the environment.